ONCY Projected Dividend Yield
Oncolytics Biotech Inc ( NASDAQ : ONCY )Oncolytics Biotech is a development stage biopharmaceutical company that focuses on the discovery and development of pharmaceutical products for the treatment of cancers. Co.'s primary product, pelareorep, is an immuno-oncology viral-agent that may be a treatment for certain types of cancer and may be an alternative to or used in combination with existing cytotoxic or cytostatic therapies. Co.'s clinical development program for pelareorep centers on main immunotherapy combinations. Immunotherapy combinations in which pelareorep has the potential to provoke specific innate and adaptive immune responses when combined with checkpoint blockade therapy, chemotherapy and/or targeted therapies. 20 YEAR PERFORMANCE RESULTS |
ONCY Dividend History Detail ONCY Dividend News ONCY Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |